Literature DB >> 2336274

The contour of the juxtapapillary nerve fiber layer in glaucoma.

J Caprioli1.   

Abstract

Reliable structural markers for early glaucomatous optic nerve damage would facilitate the diagnosis of glaucoma at an early stage, possibly before visual field loss occurs. Computerized image analyses were used to develop and analyze new structural parameters for glaucomatous optic nerve damage. Multiple measurements of relative juxtapapillary nerve fiber layer height were made in glaucoma patients (n = 112), patients suspected of having glaucoma (n = 87), and in age-matched normal control subjects (n = 53). The average relative nerve fiber layer (NFL) height differed in glaucoma patients and normal subjects by 70 microns, but differences exceeded 100 microns at the superior and inferior poles of the disc. Mean values for "glaucoma suspects" were intermediate between those for the normal subjects and glaucoma groups. The ability of summary statistics of relative NFL height measurements to discriminate between normal and glaucomatous eyes was superior to that of the standard disc parameters cup-disc ratio, disc rim area, and cup volume. Measurements of relative NFL height correlated with indices of visual field loss; the strongest correlations occurred for measurements at the superior and inferior poles. Measurements of juxtapapillary NFL height may prove useful to detect glaucomatous optic nerve damage at an early stage and to accurately recognize progressive nerve damage over time.

Entities:  

Mesh:

Year:  1990        PMID: 2336274     DOI: 10.1016/s0161-6420(90)32581-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Estimation of the retinal nerve fibre layer thickness in the papillomacular area of long standing stage IV macular holes.

Authors:  A Assi; P Watts; J McAllister
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  The correlation between optic nerve head topographic measurements, peripapillary nerve fibre layer thickness, and visual field indices in glaucoma.

Authors:  Y-W Lan; D B Henson; A J Kwartz
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  GDx VCC measurements and blue-on-yellow perimetry in ocular hypertension.

Authors:  Yisheng Zhong; Liping Chen; Yu Cheng; Fangzhi Yu
Journal:  Lasers Med Sci       Date:  2012-02-03       Impact factor: 3.161

4.  An optimal reference plane to detect glaucomatous nerve fiber layer abnormalities with computerized image analysis.

Authors:  J M Miller; J Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Optic disc histomorphometry in normal eyes and eyes with secondary angle-closure glaucoma. II. Parapapillary region.

Authors:  J B Jonas; K A Königsreuther; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Retinal nerve fibre layer polarimetry: histological and clinical comparison.

Authors:  J E Morgan; A Waldock; G Jeffery; A Cowey
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

7.  RA/DA cumulative curve analysis of local and diffuse neuroretinal rim area damage in glaucoma patients.

Authors:  M Rolando; A Macrì; M Iester; M Altieri; G Calabria
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

8.  Reproducibility of the data determined by scanning laser polarimetry.

Authors:  A Junghardt; M K Schmid; I Schipper; H Wildberger; B Seifert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-10       Impact factor: 3.117

9.  Sensitivity and specificity of optic disc variables and analysis of a new variable (MP/D) for glaucoma diagnosis with the Glaucoma-Scope.

Authors:  Y Lachkar; H Cohn
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

10.  Retinal Nerve Fiber Layer Decrease during Glycemic Control in Type 2 Diabetes.

Authors:  Masahiko Sugimoto; Mikio Sasoh; Masashi Ido; Chisato Narushima; Yukitaka Uji
Journal:  J Ophthalmol       Date:  2010-08-08       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.